{
  "ticker": "NVO",
  "name": "Novo Nordisk A/S",
  "price": 51.445,
  "market_cap": 228594810880,
  "revenue_ttm": 49697581438.85413,
  "net_income_ttm": 16340995233.423668,
  "ocf_ttm": 19492100584.681133,
  "capex_ttm": 9894385769.872152,
  "sbc_ttm": 0.0,
  "buyback_ttm": 1398164230.3640518,
  "total_debt": 15938032932.995512,
  "cash_and_equivalents": 5130801342.2628565,
  "book_value_ttm": 26753295425.377964,
  "shares_outstanding": 3368607341,
  "beta": 1.2,
  "roe": 71.47,
  "analyst_growth_estimate": 5.1,
  "forward_eps": 3.4565055,
  "dividend_yield": 330.0,
  "sector_type": "BioTech",
  "currency_code": "USD",
  "last_updated": "2025-12-29T18:32:46Z"
}